Keyphrases
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
93%
Patients with COVID-19
60%
Prone Ventilation
37%
COVID-19
23%
Extracorporeal Membrane Oxygenation Support
22%
Adult Respiratory Distress Syndrome
22%
National Cohort Study
21%
Adverse Events
18%
Coronavirus Disease (COVID)
18%
Pulmonary Effects
18%
Severe Acute Respiratory Distress Syndrome
18%
Real-time Performance
18%
Intensive Care
18%
6-Month Outcome
18%
Mannan Antigen
18%
T2Candida
18%
Multicenter Observational Study
18%
Candida Mannan
18%
Stewardship Program
18%
Superinfection
18%
Antifungal Stewardship
18%
Esophagogastroduodenoscopy
18%
Acute Respiratory Distress Syndrome
18%
Severe COVID-19
18%
E-cigarette or Vaping Product Use-associated Lung Injury
18%
EVALI
18%
Invasive Candidiasis
15%
Technical Skills
15%
Pulmonary Aspergillosis
14%
Cytomegalovirus
14%
Antifungal Therapy
13%
Endoscopist
11%
Risk of Death
9%
Ventilator-associated Pneumonia
9%
Bacteremia
9%
Mortality Risk
9%
Denmark
8%
Dynamic Compliance
8%
Competencies
7%
Cannulated
7%
COVID-19 Patients
5%
Medicine and Dentistry
Extracorporeal Membrane Oxygenation
100%
COVID-19
75%
Cohort Analysis
56%
Acute Respiratory Distress Syndrome
56%
Prone Position
37%
Observational Study
18%
Esophagogastroduodenoscopy
18%
Adverse Event
18%
Coronavirinae
18%
Superinfection
18%
Virus Infection
18%
Electronic Cigarette
18%
Vaping
18%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
18%
Lung Aspergillosis
11%
Cytomegalovirus
11%
Intensive Care Unit
10%
Diagnosis
9%
Intubation
9%
Ventilator-Associated Pneumonia
7%
Bacteremia
7%
Respiratory Failure
6%
Awareness
6%
Interstitial Lung Disease
6%
